Le Lézard
Classified in: Health
Subjects: CCA, FVT

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2019


LITTLE FALLS, N.J., Nov. 25, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its first quarter ended October 31, 2019 on Tuesday, December 10, 2019 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.

(PRNewsfoto/Cantel Medical Corp.)

To participate in the conference call, dial 1-844-602-0380 (US & Canada) or 1-862-298-0970 (International) approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Tuesday, December 10, 2019 through midnight on January 22, 2020 by dialing 1-877-481-4010 (US & Canada) or 1-919-882-2331 (International) and using conference ID #: 56794.

An audio webcast will be available via the Cantel website at www.cantelmedical.com. A replay of the presentation will be archived on the Cantel website for those unable to listen live. In addition, the Company will provide a supplemental presentation to complement the conference call. The presentation can be accessed on Cantel's website in the Investor Relations section under presentations.

About Cantel Medical Corp.

Cantel is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. The Company's products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, Cantel provides technical service for its products. 

For further information, visit www.cantelmedical.com.

SOURCE Cantel Medical Corp.


These press releases may also interest you

8 aoû 2020
LES Spine Innovations and Sagitechnology are proud to announce the launch of the new A-CIFT SoloFuse Hyperlordotic Cervical Standalone Interbody System, the first ever HA impregnated standalone cervical cage for greater sagittal correction. The...

8 aoû 2020
Symbria Inc. is pleased to announce that it is being featured in a nationally distributed television program, Behind the Scenes with Laurence Fishburne. Behind The Scenes is known for providing factual, unbiased information and specializes in mining...

8 aoû 2020
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 118,985 cases of COVID-19 in Canada, including 8,970 deaths. 87% of people have now recovered....

8 aoû 2020
The latest data of the evolution of COVID-19 in Québec reveal 126 new cases, bringing the total number of people infected to 60,367. During this same period, 4 new deaths were recorded, to which need to be added 1 death that occurred before July 31,...

8 aoû 2020
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today...

8 aoû 2020
Bristol Myers Squibb today announced that Opdivo® (nivolumab) plus Yervoy® (ipilimumab) demonstrated a significant improvement in overall survival (OS) in patients with previously untreated, unresectable malignant pleural mesothelioma (MPM) in the...



News published on 25 november 2019 at 11:59 and distributed by: